Europe Gastroparesis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

No. of Pages: 109    |    Report Code: TIPRE00024817    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Gastroparesis Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Gastroparesis Market – By Type

1.3.2        Europe Gastroparesis Market – By Drug Class Type

1.3.3        Europe Gastroparesis Market – By Distribution Channel

1.3.4        Europe Gastroparesis Market – By Country

2.           Europe Gastroparesis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Gastroparesis Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Gastroparesis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Diabetes Mellitus Prevalence on Rise

5.1.2        Geriatric Population Rising

5.2         Market Restraints

5.2.1        Gastroparesis Drugs Having Side Effects

5.3         Market Opportunities

5.3.1        Rising Financial Assistance for Research

5.4         Future Trends

5.4.1.1          Stress on Gastric Electrical Stimulation Therapy Research

5.5         Impact Analysis

6.           Gastroparesis Market – Europe Analysis

6.1         Europe Gastroparesis Market Revenue Forecast and Analysis

7.           Europe Gastroparesis Market Analysis – By Type

7.1         Overview

7.2         Europe Gastroparesis Market Revenue Share, by Type (2019 and 2027)

7.3         Idiopathic

7.3.1        Overview

7.3.2        Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Diabetic

7.4.1        Overview

7.4.2        Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Post-Surgical

7.5.1        Overview

7.5.2        Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.           Europe Gastroparesis Market Analysis – By Drug Class Type

8.1         Overview

8.2         Europe Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

8.3         Prokinetic Agents

8.3.1        Overview

8.3.2        Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Botulinum Toxin Injection

8.4.1        Overview

8.4.2        Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Antiemetic Agents

8.5.1        Overview

8.5.2        Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.           Europe Gastroparesis Market Analysis – By Distribution Channel

9.1         Overview

9.2         Europe Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.        Europe Gastroparesis Market – Country Analysis

10.1      Overview

10.1.1     Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.1.2     Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.1       Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.2       Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.3       Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.4       Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.3     UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.3       UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.4       UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.4     France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.3       France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.4       France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.5     Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1       Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2       Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.5.3       Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.5.4       Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.6     Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.6.3       Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.6.4       Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.7     Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Europe Gastroparesis Market

11.1      Europe: Impact Assessment Of COVID-19 Pandemic

12.        Gastroparesis Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Gastroparesis Market, 2018-2020

12.3      Inorganic Growth Strategies

12.3.1     Overview

12.4      Organic Growth Strategies

12.4.1     Overview

13.        Company Profiles

13.1      Allergan Plc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Bausch Health Companies Inc. (Salix Pharmaceuticals)

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Johnson and Johnson Services, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Pfizer Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Ipca Laboratories Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4.             UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7.             France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10.          Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 13.          Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 16.          Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 19.          Recent Inorganic Growth Strategies in the Gastroparesis market

Table 20.          Glossary of Terms, Gastroparesis Market

LIST OF FIGURES

Figure 1.           Europe Gastroparesis Market Segmentation

Figure 2.           Europe Gastroparesis Market Segmentation, By Country

Figure 3.           Europe Gastroparesis Market Overview

Figure 4.           Idiopathic Segment Held Largest Share of Europe Gastroparesis Market

Figure 5.           Germany to Show Remarkable Growth During Forecast Period

Figure 6.           Europe PEST Analysis

Figure 7.           Europe Gastroparesis Market Impact Analysis of Drivers and Restraints

Figure 8.           Europe Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.           Europe Gastroparesis Market Revenue Share, by Type (2019 and 2027)

Figure 10.        Europe Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Europe Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Europe Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Europe Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Europe Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

Figure 15.        Europe Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Europe Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Europe Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Europe Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 19.        Europe Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Europe Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Europe Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Europe: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 24.        Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic in European Country Markets

Figure 31.        Growth Strategies in the Gastroparesis Market, 2018-2020

 

The List of Companies - Europe Gastroparesis Market

  1. Allergan Plc
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Ipca Laboratories Ltd.
  4. Johnson and Johnson Services, Inc.
  5. Pfizer Inc.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD